Business Wire

Tris Pharma Receives U.S. FDA Approval for Once-Daily ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, the First-and-Only Liquid Non-Stimulant ADHD Medication

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Business Wire

Tris Pharma’s Once-Daily ADHD Medication, ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, Now Available in the United States

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
wqad

Blood pressure medication recalled over elevated levels of carcinogen

WASHINGTON — Nearly 581,000 bottles of a medication used to treat high blood pressure have been recalled after tests revealed potentially cancer-causing chemicals above acceptable safety limits. Teva ...
Newsday

LI doctors advise those taking recalled blood pressure medication to check with pharmacists, physicians

Patients taking a medication used for blood pressure and sleep disorders that has been linked to a cancer-causing chemical should consult with their physicians and pharmacists if they have concerns ...
The Boston Globe

FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a ...